John Wickersham
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Biochemical and Molecular Research 1
-
- Classical Antiquity Studies 2
- Co-authors
- Zdeněk Hostomský (2 shared papers)Noriyuki Habuka (2 shared papers)Robert A. Love (2 shared papers)Hans E. Parge (2 shared papers)Ellen W. Moomaw (2 shared papers)Zuzana Hostomska (2 shared papers)Tsuyoshi Adachi (2 shared papers)Michael R. Gehring (1 shared paper)
- Journals
- The American Historical Review (2 papers)Structure (2 papers)Protein Science (1 paper)Cell (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
John Wickersham
10 papers receiving 737 citations
Peers
Comparison fields: 5 of 83
- Hepatology 366
- Infectious Diseases 136
- Virology 34
- Epidemiology 228
- Radiology, Nuclear Medicine and Imaging 142
Countries citing papers authored by John Wickersham
This map shows the geographic impact of John Wickersham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wickersham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wickersham more than expected).
Fields of papers citing papers by John Wickersham
This network shows the impact of papers produced by John Wickersham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wickersham. The network helps show where John Wickersham may publish in the future.
Co-authors
The 25 scholars most cited alongside John Wickersham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 435 | |
| 2 | 1999 | 176 | |
| 3 | 1995 | 84 | |
| 4 | 1998 | 38 | |
| 5 | 1996 | 27 | |
| 6 | 1995 | 16 | |
| 7 | 1996 | 15 | |
| 8 | PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 | 2007 | 7 |
| 9 | 1976 | 3 | |
| 10 | 1994 | 1 |
About John Wickersham
John Wickersham is a scholar working on Molecular Biology, Anthropology, Ecology, Hepatology and Infectious Diseases, having authored 10 papers that have together received 802 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (2 papers), Bacteriophages and microbial interactions (2 papers), Hepatitis C virus research (2 papers), Classical Antiquity Studies (2 papers), HIV/AIDS drug development and treatment (1 paper), Medieval Iberian Studies (1 paper), Biochemical and Molecular Research (1 paper) and Archaeological and Historical Studies (1 paper). The work is most often cited by research in Hepatology (366 citations), Infectious Diseases (136 citations), Virology (34 citations), Epidemiology (228 citations) and Radiology, Nuclear Medicine and Imaging (142 citations). John Wickersham has collaborated with scholars based in United States and Japan. Frequent co-authors include Zdeněk Hostomský, Noriyuki Habuka, Robert A. Love, Hans E. Parge, Ellen W. Moomaw, Zuzana Hostomska, Tsuyoshi Adachi, Michael R. Gehring, J. Ernest Villafranca and Camran V. Parast. Their work appears in journals such as The American Historical Review, Structure, Protein Science, Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.